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In Brief
Macrophages constitute a preferential niche for intracellular bacteria to replicate. Matalonga et al. identified an antibacterial circuit mediated by pharmacological targeting of the liver X receptor (LXR) pathway that impacts intracellular NAD metabolism and interferes with macrophage cytoskeletal rearrangements subverted by invasive bacteria.
Macrophages exert potent effector functions against invading microorganisms but constitute, paradoxically, a preferential niche for many bacterial strains to replicate. Using a model of infection by Salmonella Typhimurium, we have identified a molecular mechanism regulated by the nuclear receptor LXR that limits infection of host macrophages through transcriptional activation of the multifunctional enzyme CD38. LXR agonists reduced the intracellular levels of NAD + in a CD38-dependent manner, counteracting pathogen-induced changes in macrophage morphology and the distribution of the F-actin cytoskeleton and reducing the capability of nonopsonized Salmonella to infect macrophages. Remarkably, pharmacological treatment with an LXR agonist ameliorated clinical signs associated with Salmonella infection in vivo, and these effects were dependent on CD38 expression in bonemarrow-derived cells. Altogether, this work reveals an unappreciated role for CD38 in bacterial-host
INTRODUCTION
Macrophages are essential mediators of the innate immune response. Through phagocytosis, macrophages internalize microbial pathogens, which are subsequently killed and digested in intracellular phagolysosomes (Haas, 2007) . Several pathogenic microorganisms have, however, developed strategies to actively invade host cells and evade microbial digestion within the host endosomal system. In fact, despite their repertoire of microbicidal tools, macrophages represent niches in which many pathogens have established themselves for intracellular replication and dissemination (Price and Vance, 2014) . For example, Salmonella enterica serovar Typhimurium (S. Typhimurium) fosters its own uptake by non-phagocytic epithelial cells and phagocytic cells, and infection and intracellular survival in macrophages is required for full virulence and dissemination (Haraga et al., 2008) . Invasive Salmonellae strains can enter macrophages by several endocytic processes, including macropinocytosis induced by factors secreted by the type III secretion system (T3SS). Within infected host cells, the bacterium first uses a second T3SS to transform the phagosome into a Salmonella-containing vacuole that supports bacterial replication and then induces macrophage pyroptosis for dissemination (Guiney and Lesnick, 2005) .
Nuclear receptors are a family of ligand-activated transcription factors with diverse functions in physiology. Liver X receptors (LXRs) are nuclear receptors that can be pharmacologically activated by high-affinity agonists to subsequently regulate the expression of genes involved in lipid homeostasis. Two LXR isoforms have been identified, namely LXRa and LXRb, both of which heterodimerize with retinoid X receptors (RXRs) to positively modulate target gene expression (Hong and Tontonoz, 2014) . Apart from their metabolic functions, LXRs play important roles in the regulation of immune responses. Through different mechanisms, LXRs repress a subset of pro-inflammatory genes induced by pattern recognition receptor engagement (Ghisletti et al., 2007; Ito et al., 2015) or by interferon gamma (IFN-g) (Pascual-García et al., 2013; Lee et al., 2009 ). On the other hand, the LXR pathway is involved in the acquisition of a macrophage deactivated phenotype (A-Gonzalez et al., 2009) .
Based on the anti-inflammatory actions of LXR agonists, initial predictions anticipated that LXR activation could negatively impact the capability of immune cells to establish an aggressive response against pathogens. However, increased susceptibility to infection by Mycobacterium tuberculosis or Listeria monocytogenes has been observed in LXR-deficient mice (Joseph et al., 2004; Korf et al., 2009) , and LXR activation prevented macrophage apoptosis induced by virulent bacteria, including Bacillus anthracis and S. Typhimurium (Valledor et al., 2004) , which suggests that the LXR pathway exerts complex regulatory actions that affect microbe-host cell interaction. In this work, we have further investigated the involvement of LXR activity in immune cell function during infection by S. Typhimurium. Interestingly, the results reported here identify a molecular mechanism regulated by LXRs that serves to limit infection of host macrophages through modulation of cellular NAD metabolism.
RESULTS

LXR Activity Limits Macrophage Infection by S. Typhimurium
To investigate the role of the LXR pathway in host-pathogen interaction, we treated primary bone-marrow-derived macrophages with synthetic high-affinity LXR agonists (either TO901317 (T1317) or GW3965) and then infected the cells with S. Typhimurium strain SV5015 harboring the plasmid pBR.RFP.1, which encodes red fluorescent protein. Confocal fluorescence microscopy studies indicated that LXR agonists reduce the amount of intracellular bacteria and the percentage of infected macrophages after 30 min of infection ( Figures 1A,  S1 , and S2A). Reduced bacteria burden was corroborated with flow cytometry studies (Figures 1B and S2B) and by determination of viable bacterial colony-forming units (CFUs) after macrophage cell lysis ( Figure 1C ). The agonists did not inhibit infection of cells deficient in LXRa and LXRb (LXR À/À ) ( Figures 1A, 1B , and S2B), indicating that the effects of these compounds were LXR dependent and LXR specific. Interestingly, the rate of intracellular bacterial replication during the first 5 hr post-infection was not altered upon LXR activation, as the differences between agonist-and vehicle-treated cells over a time-course of 5 hr were equivalent to the differences observed at 30 min of infection ( Figure 1D ). These results suggested that LXR activation interferes with early events during bacterial cell interaction with host macrophages. On the other hand, a time-course assay revealed that prolonged treatment with the LXR agonist is required for effective inhibition of macrophage infection ( Figure 1E ).
Pharmacological treatment with T1317 in vivo also reduced intracellular macrophage infection by S. Typhimurium in an intraperitoneal model of infection ( Figure 1F) . Importantly, the effects of T1317 were not indirectly mediated by any substantial decrease in the ratio of resident macrophages versus neutrophils before the infection ( Figure S2C ). Interestingly, the LXR agonist did not influence phagocytosis of immunoglobulin G (IgG)-opsonized Salmonella cells ( Figure 1G ), suggesting that LXR activation induces a mechanism that protects macrophages from infection by this microorganism in the absence of opsonizing antibodies.
We next determined whether LXR activation affects the internalization of other bacterial pathogens. These studies revealed that LXR activity inhibits macrophage infection by an enteroinvasive strain of Escherichia coli (EIEC 0124:H30) without affecting phagocytosis of non-invasive E. coli ( Figure S2D ) or internalization of Fluoresbright yellow green microspheres ( Figure S2E ), thus suggesting that LXR activity selectively affects invasive mechanisms induced by pathogenic bacteria.
Morphological studies using fluorescent phalloidin to stain filamentous actin (F-actin) showed that macrophages incubated with S. Typhimurium acquire a round pancake-like shape within minutes after bacterial exposure ( Figure 1H ), a morphological feature previously associated to inflammatory macrophage polarization (McWhorter et al., 2013) . Remarkably, pretreatment with an LXR agonist strongly inhibited the changes in macrophage morphology induced upon S. Typhimurium infection without altering the morphology of resting cells ( Figure 1H , see quantification in Figure 2E ). Moreover, LXR activation also reduced the expression of several pro-inflammatory mediators in infected macrophages ( Figure S2F ).
Interestingly, expression profiling experiments revealed that interference with bacterial internalization was not mediated by repression of membrane receptors traditionally involved in recognition and/or phagocytosis of bacterial products ( Figure S3) .
A recent study demonstrated a role for cytosolic nicotinamide adenine dinucleotide (NAD + ) in the control of the organization of the actin cytoskeleton required for the spreading performance and the formation of actin-rich membrane protrusions in activated macrophages (Venter et al., 2014) . Based on these observations, we evaluated whether altering NAD + levels affects the capability of LXRs to interfere with macrophage morphology and/or internalization of S. Typhimurium. In mammalian cells, nicotinamide phosphoribosyltransferase (NAMPT) is the ratelimiting enzyme in the biosynthesis of NAD + through the salvage pathway. Incubation with FK866, a specific NAMPT inhibitor, resulted in partial inhibition of the capability of macrophages to internalize S. Typhimurium ( Figure 2A ). Interestingly, activation of the LXR pathway significantly reduced the intracellular levels of NAD + ( Figure 2B ), and addition of exogenous NAD + counteracted the ability of the LXR agonist to reduce macrophage infection ( Figure 2C ), with no effect on the levels of infection in control macrophages (not exposed to LXR agonists). These effects correlated with the observation that in the presence of exogenous NAD + , activation of the LXR pathway did not inhibit morphological changes associated with host cell-pathogen interaction ( Figures 2D and 2E) . In activated macrophages, changes in macrophage morphology are accompanied by an increase in F-actin-rich dorsal membrane ruffling, with curved or circular protrusions directed upright that precede macropinocytosis (Luo et al., 2014) . Interestingly, the LXR agonist interfered with dorsal F-actin accumulation in Salmonella-infected cells, and addition of exogenous NAD + counteracted these effects. Altogether, these observations prompted us to consider whether LXR activation modulates the expression of factors that contribute to NAD + metabolism as a mechanism protecting macrophages from excessive bacterial internalization.
LXR Agonists Induce the Expression of the NAD Glycohydrolase CD38
In general, NAD + and its phosphorylated and reduced forms participate as coenzymes in oxidation-reduction reactions without net consumption of intracellular NAD. In contrast, NAD + is consumed as a substrate by enzymatic activities that mediate protein lysine deacylation and ADP-ribose transfer or synthesis (Belenky et al., 2007) . To assess if LXR activation modulates the expression of enzymes that participate in NAD + biosynthesis or consumption, we analyzed expression-profiling data obtained from macrophages stimulated with an LXR agonist ( Figure 3A ). The expression of most of the genes evaluated, including Nampt, was not altered upon LXR activation. However, selective induction of Cd38 was observed in cells treated with the LXR agonist. CD38 is a type II transmembrane glycoprotein that catalyzes the conversion of NAD + into nicotinamide, adenosine diphosphate-ribose (ADPR), and cyclic ADPR (cADPR) (Chini, 2009 ) and is thus a major regulator of cellular levels of NAD + (Aksoy et al., 2006) . Induction of CD38 upon LXR activation was confirmed by qPCR ( Figures 3B and 3C ) and western blotting ( Figure 3D ). It is noteworthy that the basal levels of Cd38 expression were not significantly reduced in LXR-deficient cells, as it is the case for previously identified LXR target genes (e.g., Abca1, Abcg1, and Srebp1c; Wagner et al., 2003) ; however, Cd38 induction by the LXR agonist was LXR dependent and LXR specific ( Figure 3B ). Cd38 expression was also upregulated in response to a synthetic agonist for RXR, LG268 ( Figure 3B ), and combined treatment with agonists for LXR and RXR synergistically upregulated CD38 mRNA and protein expression (Figures 3B, 3E, and 3F) in an LXR-dependent manner, with both LXRa and LXRb contributing to Cd38 induction (Figure 3F) . Moreover, these effects translated into increased CD38 protein levels at the cell surface (Figure 3G) and augmented cellular NADase activity ( Figures 3H-3J ). The changes in NADase activity were completely abolished in either LXR À/À or CD38 À/À macrophages ( Figures 3I and 3J ), which correlated with the fact that LXR/RXR agonists significantly downregulate intracellular NAD + levels in wild-type (WT) cells ( Figure 2B ), but not in CD38-deficient cells ( Figure 3K ). Taken together, these results indicate that CD38 mediates the increase in NADase activity and the reduction in intracellular NAD levels upon pharmacological activation of the LXR pathway.
A putative LXR response element (LXRE) was identified in an enhancer $2 kb upstream of the transcription initiation site, which is fully conserved at least in mouse and rat. A fragment containing the potential LXRE, hereafter named Cd38 enhancer (Cd38enh), was cloned in a pGL3-promoter vector (pGL3-Cd38enh), and its activity was characterized in COS-7 cells. Cotransfection of LXRa and RXRa resulted in maximal induction of promoter activity in response to a combination of LXR and RXR agonists ( Figure S4 ). Significant loss of activity was observed after mutation of the potential LXRE in the Cd38enh region, which suggests that the site identified here represents a bona fide LXRE ( Figure 3L ).
Cooperative Effects of LXRs and Inflammatory Signals on CD38 Expression and NADase Activity
Interestingly, infection by S. Typhimurium strongly induced macrophage expression of Cd38 ( Figure 4A ). In agreement with previous observations (Musso et al., 2001; Iqbal and Zaidi, 2006; Lee et al., 2012) , increased expression of Cd38 was observed upon prolonged stimulation with IFN-g, lipopolysaccharide (LPS), or tumor necrosis factor alpha (TNF-a) . In contrast, Cd38 was not upregulated in macrophages alternatively activated by interleukin 4 (IL-4), IL-10, or transforming growth factor beta (TGF-b) ( Figure 4C ), despite the fact that these cytokines did induce specific target genes in macrophages ( Figures S5D-S5F ). In line with increased Cd38 expression in classically activated macrophages, inflammatory mediators reduced intracellular NAD + levels in a CD38-dependent manner ( Figure 4D ). However, despite the ability of CD38 to alter intracellular NAD + levels, early ROS production in response to inflammatory signaling was CD38 independent ( Figure 4E ).
These studies also led to the unexpected observation that functional LXR expression was required for full induction of Cd38 by inflammatory signals and that combined activation of inflammatory signaling and the LXR pathway cooperated synergistically to upregulate Cd38 expression ( Figures 4A, 4B , and S5A-S5C) and NADase activity (Figures 4F and S5G) . Sequence analysis of the Cd38enh region containing the LXRE revealed the presence of two nuclear factor kB (NF-kB) binding sites, an interferonstimulated response element (ISRE), and an AP-1 site in the proximity of the LXRE. Raw264.7 macrophages that stably express human LXRa were cotransfected with the Cd38enh-luciferase reporter and a plasmid overexpressing RXRa. In these studies, cooperation of the LXR pathway with LPS signaling occurred at the transcriptional level, and these effects were abolished when the cells were transfected with the mutant LXRE ( Figure 4G ).
CD38 Mediates the Protective Effects of LXR Agonists on Macrophage Infection
We next compared the capability of an LXR agonist to protect WT and CD38-deficient macrophages from infection by S. Typhimurium. Importantly, the lack of functional expression of CD38 inhibited the capability of the LXR agonist to reduce the amount of infected macrophages and intracellular bacteria ( Figure 5A ), effects that were similar to those obtained upon addition of exogenous NAD + in WT cells ( Figure 2C ). Moreover, activation of macrophages by IFN-g has been shown to regulate negatively their capability to internalize non-opsonized bacteria in certain models of infection (Wang et al., 2014; Sun and Metzger, 2008) . Interestingly, in our studies, prolonged stimulation with IFN-g resulted in decreased infection by non-opsonized Salmonella cells in a CD38-dependent manner ( Figure 5B ). Taken together, these results suggest that induction of macrophage CD38 expression represents a strategy to limit infection of macrophages by live Salmonella cells. We also determined the inflammatory response to infection in CD38-deficient macrophages ( Figure 5C ). To our surprise, the levels of induction of several cytokines were significantly lower in CD38-deficient cells as compared to WT cells. However, for most of the genes examined, LXR agonists were able to repress inflammatory gene expression in cells lacking functional CD38. These data suggest that CD38 selectively facilitates protection against invasive bacterial cell entry but does not contribute broadly to the LXR-mediated anti-inflammatory response in vitro.
Intrinsic to its NADase activity, CD38 mediates the synthesis of ADPR, cADPR, and nicotinic acid adenine dinucleotide phosphate (NAADP), which are Ca 2+ mobilizing compounds (Musso et al., 2001) . Video microscopic measurements from fura-2-AM-loaded cells showed higher basal levels of cytosolic Ca 2+ in WT macrophages than in LXR-deficient cells ( Figure 5D , top). However, Ca 2+ storage in the endoplasmic reticulum (ER)
was not depleted by prolonged treatment with the LXR agonist or by addition of exogenous NAD + , as shown in experiments in which the cells were acutely stimulated with the sarco-ER Ca
2+
ATPase inhibitor thapsigargin ( Figure 5D, bottom) . Altogether, these results suggest that induction of the LXR-CD38 circuit has no substantial long-term impact on Ca 2+ depletion from the ER in macrophages. In addition, incubation of WT cells with S. Typhimurium did not lead to significant cytosolic Ca 2+ changes in either the presence or absence of an LXR agonist ( Figure 5E ), and treatment with 8-bromo-cADPR, an analog of cADPR that blocks Ca 2+ release mediated by ryanodine-receptor-gated stores, did not affect the capability of LXRs to inhibit macrophage infection ( Figure 5F ). Based on all of these observations, we conclude it is the CD38-dependent reduction in NAD + levels (a consequence of its strong NADase activity) and not the concomitant generation of potential Ca 2+ -mobilizing second messengers that best explains the protective effects on macrophage infection induced by the LXR-CD38 axis. Importantly, lack of functional CD38 expression counteracted the capability of an LXR agonist to inhibit changes in F-actin redistribution and cell morphology associated with bacterial infection (Figures 5G-5I ).
An Endogenous Pathway Can Activate the LXR-CD38 Axis during Salmonella Infection Endogenous LXR ligands are generated enzymatically from intermediates of the cholesterol biosynthetic pathway or by oxidation of cholesterol by sterol hydroxylases (Spann et al., 2012) . Interestingly, infection of macrophages with S. Typhimurium resulted in reduced expression of several enzymes involved in cholesterol biosynthesis but a selective prominent increase in the expression of cholesterol 25-hydroxylase (Ch25h), which mediates cholesterol oxidation to 25-hydroxycholesterol (25-HC) ( Figure 6A ). 25-HC is a relatively weak LXR activator that is able to induce LXR-mediated transcriptional activity at high doses (Lala et al., 1997; Janowski et al., 1999) . In our studies, micromolar doses of 25-HC induced the expression of Cd38, either alone or in synergy with IFN-g ( Figure 6B ), and reduced macrophage infection in an LXR-and CD38-dependent manner ( Figures 6C and 6D ). 25-HC can modulate inflammatory responses both positively and negatively in different settings (Reboldi et al., 2014; Gold et al., 2014) . In macrophages infected with Salmonella, 25-HC exerted dose-dependent repression of inflammatory genes ( Figure 6E ). However, these actions were independent of the LXR-CD38 pathway ( Figure 6E ), in contrast to (legend continued on next page) the role in macrophage bacterial infection. Altogether, these observations suggest that induction of CH25H during the host innate response against Salmonella may provide local endogenous LXR agonists that limit subsequent macrophage infection through the LXR-CD38 circuit and, in parallel, activate mechanisms that are independent of LXRs to further keep inflammatory responses under control.
Pharmacological Treatment with a Synthetic LXR Agonist Ameliorates the Clinical Signs Associated with Bacterial Infection In Vivo
Based on the findings described throughout this work, we next analyzed whether pharmacological treatment with a synthetic agonist has protective effects on Salmonella infection in vivo. Mice were administered either vehicle or the LXR agonist T1317 daily during the course of a lethal infection with S. Thyphimurium and monitored for the first 5 days post-infection. Remarkably, pharmacological LXR activation resulted in a significant decrease in body mass loss and in the severity of the clinical score during the course of infection ( Figures 7A and 7B ). The ameliorating effects of the agonist were abolished in animals deficient in LXRs ( Figures 7C and 7D ) or CD38 ( Figures 7E and 7F) . In LXR À/À mice, in fact, treatment with T1317 accelerated the loss of weight associated to infection. Moreover, in WT mice, but not in CD38 À/À mice, the agonist decreased the infection index of splenocytes 4 days after the start of infection ( Figures 7G and 7H) as well as the expression of several markers of inflammation in the liver and spleen ( Figure S6 ), suggesting that pharmacological activation of LXRs inhibited the capability of orally administered Salmonella to disseminate and infect distant organs. To evaluate the specific contribution of bone-marrow-derived CD38-expressing cells, we analyzed the response to infection in mice that had been sub-lethally irradiated and transplanted with either WT or CD38-deficient bone marrow. Interestingly, activation of the LXR pathway did not reduce the loss of body weight and other clinical signs associated with infection in mice reconstituted with CD38 À/À bone marrow, in contrast to the ameliorating effects observed in mice transplanted with WT bone marrow ( Figures 7I-7J ). In correlation with these observations, treatment with the LXR agonist significantly inhibited the infection index of splenocytes ( Figure 7K ) and the expression of several inflammatory genes in WT, but not CD38-deficient, bone marrow recipients ( Figure S7 ). Collectively, these results suggest that CD38 induction in bonemarrow-derived cells is an important mediator of the ameliorating actions of the LXR pathway in Salmonella infection.
DISCUSSION
In this study, we have identified a previously unappreciated strategy to inhibit the potential of S. Typhimurium to infect host macrophages based on pharmacological targeting of the LXR pathway. A key finding of our work is the mechanism that accounts for these protective effects, which involves transcriptional upregulation of the multifunctional enzyme CD38. Interestingly, LXR activation did not interfere with phagocytosis of IgG-opsonized bacteria, suggesting that the protective effects of LXR agonists do not interfere with bacterial clearance through Fcg receptors once the adaptive immune system has generated opsonizing antibodies against the pathogen. A role for CD38 in the host response against bacteria has been previously proposed based on increased susceptibility of CD38-deficient mice to other bacterial strains, in correlation with defects in immune cell infiltration to sites of infection (Partida-Sá nchez et al., 2001; Lischke et al., 2013) or with defective polarization of Th1 immune responses (Viegas et al., 2007) . In this work, we describe a previously unrecognized function of CD38 in mediating macrophage protection from invasive bacterial infection. The major enzymatic activity of CD38 is considered to be its NADase activity, as it hydrolyzes 100 molecules of NAD + to generate 1 molecule of cADPR (Aksoy et al., 2006 ). In the model we propose here, LXR activation reduces NAD + levels as a consequence of elevated CD38 expression, resulting in cytoskeletal changes that interfere with membrane ruffling and/or other mechanisms subverted by invasive bacterial strains. Consistent with this model, addition of NAD + reverted the changes in cell morphology and dorsal F-actin accumulation in macrophages and rescued the capability of S. Typhimurium to infect macrophages in the presence of an LXR agonist. The virulence of invasive Salmonella strains correlates with their capability to induce extensive cell membrane ruffling and macropinocytosis and enter inside macrophages via ''spacious phagosomes'' (Kiama et al., 2006; AlpucheAranda et al., 1995) . Among the effectors secreted by S. Typhimurium, cell invasion protein A increases the actin polymerization rate (Lilic et al., 2003) and Salmonella outer protein E enhances the activity of host cell Rho family GTPases involved 
(legend continued on next page)
in the regulation of the cytoskeleton (Hardt et al., 1998) . Moreover, NAD + is used as a cofactor to sustain the glycolytic activity in macrophages and generate ATP for polymerization of F-actin filaments and may also modulate actin dynamics through several other mechanisms (Yin et al., 2012; Venter et al., 2014) . We have identified a functional LXRE that conferred LXR/RXR agonist responsiveness to a Cd38 enhancer-directed luciferase construct. Interestingly, CD38 expression can be also induced by other members of the nuclear receptor family, including retinoic acid receptor alpha (Drach et al., 1994) and peroxisome proliferator-activated receptor gamma ). Although we cannot discard possible cooperation between other RXR heterodimeric partners and LXRs, the induction of macrophage CD38 by LXR/RXR agonists and the protective mechanism uncovered here depends on functional LXR expression, suggesting that these effects are mediated directly by LXR-RXR heterodimers.
Another major insight from this report is that cooperative actions between LXRs and inflammatory signals translate into synergistic induction of CD38 expression and its NADase activity. Our reporter studies suggest that these effects occur through combined actions at the transcriptional level, which contrasts with general mutually repressive activities between LXRs and LPS or IFN-g (Castrillo et al., 2003; Ghisletti et al., 2007; Pascual-García et al., 2013) . Our results support the notion that such cooperative regulation of macrophage CD38-dependent NADase activity represents a protective mechanism to control excessive internalization of live bacterial cells. This mechanism may be induced endogenously to some extent through induction of CH25H during infection and subsequent production of the oxysterol 25-HC. Micromolar doses of 25-HC resulted in CD38 upregulation and protection from macrophage infection in an LXR-and CD38-dependent manner, raising the possibility that, within infected tissues, intracellular or locally secreted 25-HC levels that reach the threshold to activate the LXR pathway, in combination with inflammatory mediators, contribute to limit intracellular macrophage infection.
Importantly, pharmacological treatment with a high-affinity LXR agonist ameliorated the levels of infection in the spleen and the clinical signs of disease after oral administration of S. Typhimurium in a CD38-dependent manner. Once they have infected intestinal epithelial cells, Salmonella cells continue to disseminate to other organs and their intracellular life within macrophages is essential for dissemination. We therefore hypothesize that pharmacological activation of the LXR-CD38 circuit, most probably enhanced by mediators in the inflammatory milieu, protects uninfected macrophages from posterior infection, therefore restraining the capability of Salmonella cells to disseminate throughout the body. Moreover, the LXR agonist also exerts anti-inflammatory actions that contribute to amelioration of the severity score of disease. Interestingly, despite the fact that LXR agonists repress macrophage inflammatory gene expression independently of CD38 in vitro, the induction of a number of inflammatory mediators in both the spleen and the liver of Salmonella-infected animals was downregulated by the LXR agonist in WT, but not CD38-deficient, mice. We interpret that two mechanisms affecting the extent of inflammation may be operating simultaneously in vivo: on one hand, LXR may repress the inflammatory response independently of CD38, and, on the other hand, the LXR-CD38 axis protects macrophages from infection, thus reducing bacterial dissemination to other organs and indirectly contributing to downregulated inflammation. Beyond these considerations, we cannot discard the contribution of other mechanisms regulated by LXRs, such as induction of SPa/AIM, a protein that protects macrophages from bacterial-induced cell death (Joseph et al., 2004; Valledor et al., 2004) and regulates autophagy during mycobacterial infection (Sanjurjo et al., 2015) . Importantly, our bone marrow transplantation studies provide evidence that the expression of CD38 specifically in bone-marrow-derived cells is important for the LXR-mediated effects described here, including the reduction in the levels of splenocyte infection, the extent of inflammation, and other clinical signs associated with Salmonella infection. Our studies, however, do not exclude that CD38 expression in bone-marrow-derived cells other than macrophages (e.g., neutrophils) contributes to the observed effects of the LXR agonist in vivo. Indeed, the concerted activities of CD38 seem to favor the extracellular permanence of invasive bacterial strains, as suggested here, and the chemotaxis of neutrophils to sites of infection (Partida-Sá nchez et al., 2001) , which may, in parallel, promote extracellular bacterial killing and limit macrophage-mediated dissemination. In consideration of evolving antimicrobial resistance in certain parts of the world, this work strengthens the relevance of LXR agonists or drugs that potentiate CD38 NADase activity as potential therapeutic strategies in host-directed therapy against infections that use the macrophage as a niche for replication.
EXPERIMENTAL PROCEDURES
See Supplemental Experimental Procedures for more information.
Animal Strains
All the protocols requiring animal manipulation have been approved by the ethical committee from Parc Científic de Barcelona, University of Barcelona, Mayo Clinic and Institut Pasteur in Montevideo.
Cell Cultures
Bone-marrow-derived macrophages were obtained from bone marrow precursors differentiated for 6-7 days in DMEM (PAA Laboratories) supplemented with 20% heat-inactivated fetal bovine serum (FBS) (PAA) and 30% L-cell conditioned medium. Both female and male mice were used indistinctively for generation of primary macrophages. Raw264.7 macrophages and COS-7 (ATCC) cells were grown in DMEM 10% heat-inactivated FBS.
In Vitro Infection
Macrophages were plated in cell culture plates containing DMEM 10% FBS and infected with S. Typhimurium or E. coli for 30 or 60 min at different . Non-internalized bacterial cells were eliminated by three washes with PBS. In some experiments, macrophages were then incubated for 1 hr in complete medium containing 100 mg/mL gentamicin (Sigma-Aldrich) to kill extracellular bacteria and then switched to complete medium with a lower dose of gentamicin (10 mg/mL) and processed at different times post-infection. In some experiments, S. Typhimurium was opsonized with anti-Salmonella LPS IgG (Santa Cruz Biotechnology) for 2 hr at 4 C.
Determination of Macrophage Infection by Flow Cytometry
Infected cells were fixed in PBS 4% paraformaldehyde, and cells containing fluorescent bacteria (RFP+) were counted using a FacsAria I SORP sorter (Becton Dickinson). In each experiment, non-infected cells were used as internal controls of macrophage auto-fluorescence, and cells infected at 4 C were used to distinguish attached versus internalized bacteria. For more detailed information, see Supplemental Experimental Procedures.
Confocal Fluorescence Microscopy
Infected macrophages were washed with PBS and fixed with 4% paraformaldehyde for 10 min. After two additional washes with PBS, the cells were incubated with wheat germ agglutinin (WGA)-Alexa 488 (2.5 mg/mL, 10 min) or Bodipy-fluorescein isothiocyanate (FITC) (4 mg/mL, 30 min) (Life Technologies) to stain cell membranes. In some experiments, F-actin filaments were stained with phalloidin-Alexa 633 (Life Technologies) (10 mg/mL) for 30 min at 37 C. Cell nuclei were stained with DAPI
(1 mg/mL) for 5 min, whereas intracellular bacteria were detected by RFP emission. The cells were mounted in Vectashield (Vector Laboratories). Confocal images and z stack sections were acquired using Leica TCS SP2 and SP5 confocal microscopes (Leica Microsystems) and processed with ImageJ software. Five random fields per coverslip were recorded and, in each experiment, at least triplicate coverslips were generated for each condition.
In Vivo Infection
In experiments evaluating the clinical signs of infection, adult (3-5 months old) WT, LXR-deficient, or CD38-deficient female mice were pretreated with 10% sodium bicarbonate for 10 min and then infected by oral gavage with S. Typhimurium (10 7 CFU in 200 mL saline solution per animal). To evaluate the effects of LXR activation on morbidity, the animals were daily administered by intraperitoneal (i.p.) injection either vehicle (DMSO) or the LXR ligand T1317 (15 mg/kg animal) dissolved in physiologic saline, starting 24 hr prior to infection. Each animal was daily monitored for weight changes and other parameters associated with infection-induced morbidity, and a clinical scoring system was defined according to the development of any of the following clinical signs (one point for each sign): >15% weight loss, severe hunched position, ruffled fur, watery eyes, or slow movement. In some experiments, the mice were sacrificed at day 4 post-infection, and the infection index in the spleen was determined. In these assays, the spleens were disaggregated through a 100-mm cell strainer, and the erythrocytes were lysed using 1X Pharm Lyse lysing solution (BD Biosciences). The splenocytes were fixed in PBS 5% paraformaldehyde, and the percentage of infected cells (containing RFP+ bacteria) was analyzed by flow cytometry. An infection index was calculated for each animal by using the following formula: infection index = (percentage of RFP+ splenocytes) 3 (mean fluorescence intensity in the RFP+ population). Spleen samples from non-infected mice were used as negative controls.
Irradiation and Bone Marrow Transfer
Eight-week-old C57BL/6 females were sub-lethally irradiated with two sessions of 4.5 Gy separated by 4 hr. The animals were then injected with 3 3 10 6 bone marrow cells from either WT or CD38-deficient female donors.
These procedures were carried out at the animal facility of Parc de Recerca Biome`dica Barcelona (PRBB). Two months after the bone marrow transfer, the mice were treated with an LXR agonist or vehicle and infected with S. Typhimurium as indicated above. Blood, spleen, and bone marrow specimens from non-infected mice were used to analyze the efficiency of replacement of the hematopoietic system. In these assays, surface CD38 expression was analyzed through flow cytometry. See Supplemental Experimental Procedures for more information.
RNA Extraction and Quantitative Real-Time PCR Determination
Total RNA was extracted using TRIzol Reagent (Life Technologies) as recommended by the manufacturer. More information on cDNA synthesis and quantitative real-time PCR (real-time qPCR) can be found in Supplemental Experimental Procedures. Primers used for measuring specific gene expression are described in Table S1 .
Protein Extraction and Western Blot Analysis
Cells were washed in cold PBS and lysed on ice in RIPA buffer (25 mM Tris-HCl [pH 7.6], 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, and 0.1% SDS) supplemented with protease inhibitors. The samples were processed as described in Supplemental Experimental Procedures.
NAD Cycling Activity
To determine intracellular NAD + levels, 3 3 10 6 macrophages were lysed in 10% trichloroacetic acid (TCA) (Sigma-Aldrich) by sonication. Sonicated samples were centrifuged at 12,000 rpm for 2 min. The supernatants were collected, and the pellets were resuspended in 0.2 N NaOH for protein determination. TCA extraction was performed on the supernatants by adding 2 vol 1,1,2-trichloro-1,2,2-trifluroethane and 3 vol trioctylamine. After phase separation, the top aqueous layer containing NAD + was recovered, and its pH was adjusted to 8.0. In a 96-well plate, 100 mL of each sample diluted in water was mixed with 100 mL of a cycling reagent solution (100 mM NaH 2 PO 4 [pH 8], 0.76% ethanol, 4 mM riboflavin 5 0 -monophosphate, 27.2 U/mL alcohol dehydrogenase, 0.24 U/mL diaphorase, and 8 mM resazurin) and incubated for 20 min in the dark. The samples were monitored every min for 60 min in a fluorescence plate reader (excitation wavelength = 544 nm; emission wavelength = 590 nm). A standard curve with known concentrations of NAD + was used to determine the amount of NAD + in the processed samples. The data were normalized by the amount of protein in each sample.
NADase Activity NADase activity was measured using a fluorescence-based assay. In each sample, 5 3 10 6 macrophages were lysed by sonication in Sucrose-Tris buffer 
Statistical Analysis
Statistical analyses were performed with SPSS software (IBM). For data with normal distribution, an ANOVA Bonferroni test or a Student's t test was used to determine statistical differences between multiple or paired comparisons, respectively. Instead, a Kruskal-Wallis Dunn's test or a Mann-Whitney U Wilcoxon test was used for data without normal distribution. In experiments evaluating changes of body weight along the course of infection, a repeated-measures two-way ANCOVA was used, adjusting for weight at day 0 of infection. Differences were considered significant when p < 0.05. To make different experiments comparable in Figures 1A and 2C , the data were normalized using the following procedure. The intensity of each experiment (i e ) was calculated by determining the mean value of infection between the vehicle-treated control and the T1317-treated WT cells. The intensities of separate experiments were normalized by the mean intensity value of all the experiments (i m ) and, for each experiment, the resulting normalization factor (i m /i e ) was multiplied with the percentage of infected cells of all the samples in that experiment. Similar calculations were applied to Figures 3G, 3L, 4D , and 4G.
The accession number for the microarray datasets reanalyzed in this work is MIAMExpress: E-MEXP-3871 (Pascual-García et al., 2013) .
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